An anti-obesity drug that inhibits gastric, pancreatic, and carboxyl ester lipases, preventing hydrolysis of triglycerides to free fatty acids and monoglycerides; potently inhibits human recombinant DAGLα (IC50 = 60 nM) and at 1 µM inhibits the formation of 2-AG in intact cells.